Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond

Here are five significant industry trends that are impacting the drug wholesaling industry. Details and underlying data are available in DCI’s new industry report.

1) Wholesalers’ U.S. drug distribution revenues continue to expand, driven by utilization of anti-obesity medications and overall pharmaceutical demand.

DCI projects that drug distribution revenues for the Big Three wholesalers will reach $776 billion for 2024. The chart below, one of 178 in our new report, highlights the year-over-year changes in the largest companies’ aggregated quarterly U.S. drug distribution revenues.